Literature DB >> 3389868

Clinical factors associated with retinopathy of prematurity.

A Prendiville1, W E Schulenburg.   

Abstract

In the period from September 1983 until June 1986 a prospective study was carried out to determine the incidence and severity of retinopathy of prematurity in inborn infants of less than 1500 g at birth and the risk factors associated with the development of retinopathy of prematurity in infants of less than 31 weeks' gestation. One hundred and forty four infants were eligible for inclusion in the study. Altogether 140 infants of less than 1500 g birth weight were examined, 42 (30%) of whom developed retinopathy of prematurity. Fifteen of these infants had progression to advanced disease (stage III or stage IV). One hundred and seventeen of the infants were of less than 31 weeks' gestation and 34 (29%) of them developed retinopathy of prematurity. Thirty four risk factors shown previously to be associated with the development of the disease were collected prospectively and analysed using multiple logistic regression analysis to determine the independently significant variables. Three risk factors: acidosis, the number of times that the pH was less than 7.2; hyperoxia, the number of times that arterial oxygen tension was greater than 12 kPa; and gestational age were found to be independently associated with the development of retinopathy of prematurity in these infants. These findings suggest that acidosis may be an important aetiological factor in the pathogenesis of this disease.

Entities:  

Mesh:

Year:  1988        PMID: 3389868      PMCID: PMC1778913          DOI: 10.1136/adc.63.5.522

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  Retrolental fibroplasia; a problem of prematurity.

Authors:  B A BEMBRIDGE; M COXON; A C L HOULTON; C R S JACKSON; V SMALLPEICE
Journal:  Br Med J       Date:  1952-03-29

2.  Cerebral blood flow during acute acidosis in perinatal goats.

Authors:  R L Bucciarelli; D V Eitzman
Journal:  Pediatr Res       Date:  1979-03       Impact factor: 3.756

3.  Factors associated with periventricular haemorrhage in very low birthweight infants.

Authors:  R W Cooke
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

4.  Acute proliferative retrolental fibroplasia: multivariate risk analysis.

Authors:  J T Flynn
Journal:  Trans Am Ophthalmol Soc       Date:  1983

5.  Incidence of retinopathy of prematurity in a tertiary newborn intensive care unit.

Authors:  P B Campbell; M J Bull; F D Ellis; C Q Bryson; J A Lemons; R L Schreiner
Journal:  Arch Ophthalmol       Date:  1983-11

6.  Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants.

Authors:  R S Procianoy; J A Garcia-Prats; H M Hittner; J M Adams; A J Rudolph
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

7.  An association between retinopathy of prematurity and intraventricular hemorrhage in very low birth weight infants.

Authors:  R S Procianoy; J A Garcia-Prats; H M Hittner; J M Adams; A J Rudolph
Journal:  Acta Paediatr Scand       Date:  1981-07

8.  Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.

Authors:  H M Hittner; L B Godio; A J Rudolph; J M Adams; J A Garcia-Prats; Z Friedman; J A Kautz; W A Monaco
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

9.  Retrolental fibroplasia--controlled study of 4 years' experience in a neonatal intensive care unit.

Authors:  V Y Yu; D M Hookham; J R Nave
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

10.  Risk factors in retrolental fibroplasia.

Authors:  T R Gunn; J Easdown; E W Outerbridge; J V Aranda
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

View more
  12 in total

1.  Is the partial pressure of carbon dioxide in the blood related to the development of retinopathy of prematurity?

Authors:  B Gellen; N McIntosh; J R McColm; B W Fleck
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

2.  Retinopathy of prematurity in surfactant treated infants.

Authors:  S J Rankin; T R Tubman; H L Halliday; S S Johnston
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

3.  Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.

Authors:  P M Pennefather; W Tin; M P Clarke; S Fritz; N P Strong
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

4.  Circulatory collapse and ROP.

Authors:  J F Acheson; W E Schulenburg
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

Review 5.  Retinopathy of prematurity.

Authors:  E Bossi; F Koerner
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

6.  The apparent role of blood transfusions in the development of retinopathy of prematurity.

Authors:  R W Cooke; D Clark; M Hickey-Dwyer; A M Weindling
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

7.  Do maternal beta-sympathomimetics influence the development of retinopathy in the premature infant?

Authors:  C A Michie; S Braithwaite; E Schulenberg; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

8.  The progression of retinopathy of prematurity and fluctuation in blood gas tension.

Authors:  Y Saito; T Omoto; Y Cho; Y Hatsukawa; M Fujimura; T Takeuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

9.  Regressed retinopathy of prematurity and its sequelae in children aged 5-10 years.

Authors:  J E Gallo; G Holmström; U Kugelberg; B Hedquist; G Lennerstrand
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

10.  Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study.

Authors:  Birgit Lorenz; Katerina Spasovska; Heike Elflein; Nico Schneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-22       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.